- Company Overview for VANTAGE PHARMACEUTICALS LTD (13095005)
- Filing history for VANTAGE PHARMACEUTICALS LTD (13095005)
- People for VANTAGE PHARMACEUTICALS LTD (13095005)
- More for VANTAGE PHARMACEUTICALS LTD (13095005)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
30 Sep 2024 | AA | Total exemption full accounts made up to 31 December 2023 | |
05 Jan 2024 | CS01 | Confirmation statement made on 21 December 2023 with no updates | |
22 Dec 2023 | TM01 | Termination of appointment of Anne-Laure Wagstaff as a director on 20 December 2023 | |
29 Sep 2023 | AA | Total exemption full accounts made up to 31 December 2022 | |
04 Jan 2023 | CS01 | Confirmation statement made on 21 December 2022 with no updates | |
20 Dec 2022 | AP01 | Appointment of Mrs Anne-Laure Wagstaff as a director on 28 July 2022 | |
13 Sep 2022 | AA | Total exemption full accounts made up to 31 December 2021 | |
06 Jun 2022 | AP01 | Appointment of Mr Jiten Mahendrakumar Raval as a director on 1 May 2022 | |
21 Dec 2021 | CS01 | Confirmation statement made on 21 December 2021 with updates | |
03 Nov 2021 | MA | Memorandum and Articles of Association | |
03 Nov 2021 | RESOLUTIONS |
Resolutions
|
|
25 Oct 2021 | SH01 |
Statement of capital following an allotment of shares on 6 September 2021
|
|
25 Oct 2021 | PSC07 | Cessation of Robert Gaurav Singh Johal as a person with significant control on 22 October 2021 | |
25 Oct 2021 | PSC01 | Notification of Melissa Pricilla Raval as a person with significant control on 22 October 2021 | |
25 Oct 2021 | PSC01 | Notification of Anne-Laure Wagstaff as a person with significant control on 22 October 2021 | |
22 Dec 2020 | NEWINC |
Incorporation
Statement of capital on 2020-12-22
|